EQUAZEN Capsules 180 Capsules

EQUAZEN can help to:

Improve attention and concentration: Helping to support focus and working memory1,2

Improve learning: Such as reading, drawing, spelling and language development1,2

Support healthy brain development: Supporting and maintaining healthy brain function and can play a role in healthy neuronal function1,2

EQUAZEN is a supplement with a specific combination and scientifically researched ratio of omega-3 and omega-6, derived from responsibly sourced fish oil and evening primrose oil. This carefully balanced formula uses a clinically trialled EQUABALANCE ratio of EPA:DHA:GLA at 9:3:1 and has been clinically researched to support concentration, enhance learning ability, such as reading and writing, and support cognitive and brain function in children.1-12

EQUAZEN is well tolerated and available as triple strength capsules, original capsules and easy-to-take strawberry flavoured chewable capsules. The EQUAZEN Forte formula is 3x more concentrated than original EQUAZEN capsules and chews. Thanks to its highly concentrated triple strength formula of essential fatty acids, EQUAZEN Forte can be taken as a convenient daily dose. Learn more about the EQUAZEN range and recommendations for taking omega oil supplements below.

EQUAZEN Chews (chewable capsules) are suitable for children from 3 years old and adults, and EQUAZEN Capsules (original) and EQUAZEN Forte capsules are suitable for children from 5 years old and adults. Product should be used under adult supervision.

Starting dose:
EQUAZEN Forte: For the first 3 months, the recommended dosage is 2 capsules daily with water.
EQUAZEN Chews and Equazen Capsules (original): For the first 3 months, the recommended dosage is 6 capsules daily.
Maintenance dose:
EQUAZEN Forte: The recommended dosage is 1 capsule daily.
EQUAZEN Chews and Equazen Capsules (original): The recommended dosage is 2 capsules daily.
Continue taking EQUAZEN daily to maintain benefits, or for as long as recommended by your healthcare professional. Effects may be felt sooner but typical results demonstrate best results after 3 months of daily use.

EQUAZEN is well tolerated in children and adults based on clinical research and years of use worldwide.  It is recommended to talk to your healthcare professional if you have any questions about using EQUAZEN.

Always read the label and follow the directions for use. Contains fish. Contains sulfites in trace amounts.

1. Johnson M et al., J Child Psychol Psychiatry. 2017 Jan;58(1):83-93. doi: 10.1111/jcpp.12614. Funded by Vifor Pharma.
2. Parletta N et al., Prostaglandins Leukot Essent Fatty Acids. 2013 Aug;89(2-3).
3. Bauer I et al., Hum Psychopharmacol. 2014 Mar;29(2):133-44.  Funded by Novasel Australia.
4. Bauer I. et al. PLoS One. 2011;6(12):e28214. Partially funded by Novatel Australia.
5. Sinn, N. and Bryan, J Dev Behav Pediatr. 2007 Apr;28(2):82-91. Study was supported by University of SA and CSIRO Human Nutrition, Equazen UK and Novasel.
6. Barragán-Pérez E.J. et al., Journal of attention disorders. Jan 24,2014.  The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Manfred Döpfner has received consulting income and research support from Lilly, Medice, Shire, Janssen Cilag, Novartis, and Vifor, and research support from the German Research Foundation, German Ministry of Education and Research, and German Ministry of Health.  Eduardo Barragán has received consulting income and research support from Lilly, UCB, Cilag, Novartis and Vifor, and research support from the Universidad Nacional Autónoma de México (UNAM).
7. Johnson, M. et al. J Atten Disord. 2009 Mar;12(5):394-401.
8. Johnson, M. et al. J Atten Disord. 2012 Dec;4(4):199-204. Equazen/Vifor Pharma, Wilhelm and Martina Lundgrens Vetenskapsfond and by the Swedish MRC (grant no 2,006–3,449).
9. Sinn N et al., Prostaglandins Leukot Essent Fatty Acids. 2008;78(4-5):311-26.
10. Barragán E, Breuer D, Döpfner M. J Atten Disord i-9. 2014. Research conducted by Barragan et al. with financial interest from Vifor pharma.
11. Richardson AJ et al., Pediatrics. 2005 May;115(5):1360-6.  The study wascofunded by the Dyslexia Research Trust and the Durham Local Education Authority.
12. Milte et al. Nutrition. 2012 Jun;28(6):670-7. Research conducted by Mite et al. with funding from Australlian Research Council with financial interest from Novasel Australia.